Bottneuro AG | Leading provider of diagnosis and treatment of AD

Who We Are

At Bottneuro AG, we are a team of dedicated individuals who are passionate about improving the diagnosis and treatment of neurological diseases.

Our team consists of biologists, materials scientists, engineers, data scientists, physicists and psychologists, and is backed up by highly experienced advisors and entrepreneurs, who bring a wealth of knowledge and experience to our mission.

Solution

Our History

Founded in 2021, Bottneuro AG is a cutting-edge medtech startup focused on improving the diagnosis and treatment of neurological diseases.

As a spin-off from the University of Basel, the company has quantitatively validated the positive effects of alternating microcurrents on glial cells, with financial support from the Gebert Rüf Stiftung. In its first year, Bottneuro successfully won all three stages of the Venture Kick Program and was recognized by Forbes Magazine as a spin-off to watch in the DACH region, solidifying its position as a leader in non-invasive treatment for Alzheimer's disease.

Solution

Our Team

Inspiration comes of working every day - but only with a positive mindset. I want to ‎ensure that technology simplifies the everyday life of all those who are particularly ‎challenged by health issues.

Dr. Bekim Osmani
Dr. Bekim Osmani
CEO and Co-Founder

I am ‎convinced that by expanding our knowledge about neurodegenerative diseases we ‎are able to limit and counteract harmful disease progression.

Dr. Alois C. Hopf
Dr. Alois C. Hopf
CSO and Co-Founder

At Bottneuro, I have taken on the challenge of digital therapy for neurodegenerative diseases, helping to expand the technology and push it towards personalised treatment.

Mahyar Joodaki
Mahyar Joodaki
Head of Digital Therapeutics

I am fascinated about psychology and neuroscience to better understand human behavior.

Annina Ruffner
Annina Ruffner
Client Service Manager

I studied business and economics at University in Basel before turning to medical informatics at FHNW in Muttenz/Olten.

Marc Funken
Marc Funken
Quality and Compliance Manager
Mathias Recalde Koller
Design Engineer

I'm inspired to help treat neurodegenerative diseases at Bottneuro.

Dr. Griffin Rodgers
Dr. Griffin Rodgers
Computational Scientist
Prof. Dr. Raphael Guzman
Prof. Dr. Raphael Guzman
Co-Founder and Clinical Advisor
Prof. Dr. phil. Andreas Monsch
Prof. Dr. phil. Andreas Monsch
Clinical Advisor
Prof. Dr. Emiliano Santarnecchi
Prof. Dr. Emiliano Santarnecchi
Scientific Advisor
Dr. Antonella Santuccione Chadha
Dr. Antonella Santuccione Chadha
Clinical Advisor
Prof. Christoph Michel
Prof. Christoph Michel
Scientific Advisor
Lucie Bréchet
Lucie Bréchet
Scientific Advisor
Patrick Griss
Patrick Griss
Advisor to the Board
Sophie Lamparter
Sophie Lamparter
Advisor US Market
Guido Mesmer
Guido Mesmer
Financial and M&A Advisor
David Eiler
David Eiler
Regulatory and QMS
Dr. Bekim Osmani
Dr. Bekim Osmani
CEO and Co-Founder
Rolf Wildermuth
Rolf Wildermuth
Chairman of the Board, Former CEO Medtronic CH
Pascal Brenneisen
Pascal Brenneisen
Board Member, Former CEO Novartis CH
Dr. Tino Töpper
Dr. Tino Töpper
Board Member, Advisor
We use cookies to personalize content and to analyze our traffic. Please decide if you are willing to accept cookies from our website.